Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

Eczema, or atopic dermatitis, is a condition that causes dry, itchy, and irritated skin. Treatment involves hydrating the skin, restoring the skin barrier, managing inflammation, and other goals.

Atopic dermatitis is the most common type of eczema, affecting approximately 9.6 million children and 16.5 million adults in the United States. ZORYVE cream 0.15% was approved by the FDA for the ...

Cases of the autoimmune skin condition eczema appear to rise in areas most plagued by air pollution, new research show ...

If not controlled with the above measures, your eczema might require prescription treatments like corticosteroids or even ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

Two studies assessed the quality and accuracy of ChatGPT recommendations for atopic dermatitis based on their concordance with clinical guidelines.

Enveda Therapeutics Inc. has received U.S. IND clearance and advanced into phase I trials with ENV-294, its naturally derived anti-inflammatory.

In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing CohortInterim Data from Atopic Dermatitis Trial ...